Our results further showed that inhibition of Sna TFs in the heart does not affect cardiac lipid metabolism gene expression, thereby arguing against a cardiac-autonomous role of Sna TFs in controlling lipid metabolism which when disrupted, could give rise to cardiac steatosis seen in the Sna TF-inhibited heart. The gene discussed is TF; the disease is steatosis.